1 Pharmaceuticals, Personal Care Products, and Artificial …
21
Table 1.4 (continued)
Detection freq.
(%)
Sample number Concentration
range (ng/L)
Country/region
References
79
14
<0.1–27.2
India (Ganges
River Basin)
Sharma et al.
(2019)
62
148
<0.3–9.3
Singapore
Tran et al.
(2014b)
60
5
<1.13–0.81
China
(Changzhou)
Jiang et al.
(2019)
58
12
<1–103.2
China (12 cities
from northern
China)
Li et al. (2015)
40
15
<0.4–117
Japan (Tokyo)
Nakada et al.
(2008)
38
50
<0.10–97
Japan (Tokyo)
Kuroda et al.
(2012)
27
26
<1–86
India (Varanasi)
Lapworth et al.
(2018)
10
30
<0.098–0.255
Korea
(Buyeo-gun)
Lee et al. (2019)
10
10
<0.09–0.25
Vietnam (Hanoi) Kuroda et al.
(2012)
9
33
ND–18.1
China
(Dongjiang
River Basin)
Yang et al.
(2018)
Crotamiton (antipruritic)
100
14
0.29–44.4
Japan (Tokyo)
This study
87
15
<1.3–592
Japan (Tokyo)
Nakada et al.
(2008)
67
30
<0.081–1.14
Korea
(Buyeo-gun)
Lee et al. (2019)
36
50
<0.51–1400
Japan (Tokyo)
Kuroda et al.
(2012)
4
148
<0.3–12.4
Singapore
Tran et al.
(2014b)
Diclofenac (anti-inflammatory and analgesic)
60
5
<1.05–7.66
China
(Changzhou)
Jiang et al.
(2019)
18
33
ND–6.03
China
(Dongjiang
River Basin)
Yang et al.
(2018)
14
14
<0.9–1.56
India (Ganges
River Basin)
Sharma et al.
(2019)
(continued)